In a recent survey of nearly 100 pharmaceutical and life science market research executives conducted by my company InCrowd, 80% identified their respective brand as being in a volatile market, characterized by disruption and uncertainty.
Meghan Oates-Zalesky on August 14, 2017
In a recent survey of nearly 100 pharmaceutical and life science market research executives conducted by my company InCrowd, 80% identified their respective brand as being in a volatile market, characterized by disruption and uncertainty.
